Improved survival after induction of sepsis by cecal slurry in PD-1 knockout murine neonates

Surgery (United States)

Volumn 161, Issue 5, 2017, Pages 1387-1393

  Young, Whitney A ^a   Fallon, Eleanor A ^a   Heffernan, Daithi S ^a   Efron, Philip A ^b   Cioffi, William G ^a   Ayala, Alfred ^a  

^a BROWN UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; PROGRAMMED DEATH 1 RECEPTOR; TUMOR NECROSIS FACTOR;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTEREMIA; BACTERIAL CLEARANCE; BACTERIAL LOAD; CECAL SLURRY; CECUM; CELL LOSS; CELL POPULATION; CONTROLLED STUDY; CYTOKINE RESPONSE; FLOW CYTOMETRY; MALE; MOUSE; NEUTROPHIL; NEWBORN; NEWBORN SEPSIS; NONHUMAN; PERITONEAL CAVITY; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STOMACH CONTENT; T LYMPHOCYTE; ANIMAL; C57BL MOUSE; DISEASE MODEL; PHYSIOLOGY; SEPSIS;

ANIMALS; ANIMALS, NEWBORN; CECUM; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; PROGRAMMED CELL DEATH 1 RECEPTOR; SEPSIS;

EID: 85008178938     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2016.11.008     Document Type: Article

References (33)

1. 1 Liu, L., Johnson, H., Cousens, S., Perin, J., Scott, S., Lawn, J., et al. Global, regional and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379 (2012), 2151–2161.
2. 2 Yost, C., Cody, M., Harris, E., Thornton, N., McInturff, A., MArtinez, M., et al. Impaired neutrophil extracellular trap (NET) formation: a novel innate immune deficiency of human neonates. Blood 113 (2009), 6419–6427.
3. 3 Haeney, M., Infection determinants at extremes of age. J Antimicrob Chemother 34:Suppl A (1994), 1–9.
4. 4 Huang, X., Venet, F., Wang, Y., Lepape, A., Yuan, Z., Chen, Y., et al. PD-1 expression by macrophages plays a pathologic role in alterting microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A 106 (2009), 6303–6308.
5. 5 Hutchins, N., Unsinger, J., Hotchkiss, R., Ayala, A., The new normal: immunomodulatory agents against sepsis immune suppression. Trends Mol Med 20 (2014), 224–233.
6. 6 Monaghan, S., Thakkar, R., Tran, M., Huang, X., Cioffi, W., Ayala, A., et al. Programmed death 1 expression as a marker for immune and physiological dysfunction in the critically ill surgical patient. Shock 38 (2012), 117–122.
7. 7 Thakkar, R., Huang, X., Lomas-Neira, J., Heffernan, D., Ayala, A., Sepsis and the immune response. Eremin, O., Sewell, H., (eds.) Essential immunology for surgeons, 2011, Oxford University Press, Oxford (United Kingdom), 303–342.
8. 8 Lewis, A., Billiar, T., Rosengart, M., Biology and metabolism of sepsis: innate immunity, bioenergetics and autophagy. Surg Infect (Larchmt) 17 (2016), 286–293.
9. 9 Chen, L., Han, X., Anti-PD-1/PD-L1 therapy of human cancer: past, present and future. J Clin Invest 125 (2015), 3384–3391.
10. 10 Monaghan, S., Thakkar, R., Heffernan, D., Tran, M., Huang, X., Chung, C., et al. Mechanisms of indirect acute lung injury: a novel role for the coinhibitory receptor programmed death-1. Ann Surg 255 (2012), 158–164.
11. 11 Weinberger, B., Laskin, D., Mariano, T., Sunil, V., DeCoste, C., Heck, D., et al. Mechanisms underlying reduced responsiveness of neonatal neutrophils to distinct chemoattractants. J Leukoc Biol 70 (2001), 969–976.
12. 12 Wynn, J., Scumpia, P., Delano, M., O'Malley, K., Ungaro, R., Abouhamze, A., et al. Increased mortality and altered immunity in neonatal sepsis produced by generalized peritonitis. Shock 28 (2007), 675–683.
13. 13 Heffernan, D., Monaghan, S., Chung, C., Cioffi, W., Gravenstein, S., Ayala, A., A divergent response of innate regulatory T-cells to sepsis in humans: circulating invariant natural killer T-cells are preserved. Hum Immunol 75 (2014), 277–282.
14. 14 Young, J., Heffernan, D., Chung, C., Kettenmann, M., Young, W., Guillen, V., et al. Effect of PD-1:PD-L1 in invariant Natural Killer T-cell emigration and chemotaxis following sepsis. Shock 45 (2016), 534–539.
15. 15 Ayala, A., Elphick, G., Kim, Y., Huang, X., Carreira-Rosario, A., Santos, S., et al. Sepsis-induced potentiation of peritoneal macrophage migration is mitigated by programmed cell death receptor-1 gene deficiency. J Innate Immun 6 (2014), 325–338.
16. 16 Shubin, N., Chung, C., Heffernan, D., Irwin, L., Monaghan, S., Ayala, A., BTLA expression contributes to septic morbidity and mortality by inducing innate inflammatory cell dysfunction. J Leukoc Biol 92 (2012), 593–603.
17. 17 Okazaki, T., Honjo, T., The PD1:PDL pathway in immunological tolerance. Trends Immunol 27 (2006), 195–201.
18. 18 Tang, L., Bai, J., Chung, C., Lomas-Neira, J., Chen, Y., Huang, X., et al. Active players in resolution of shock/sepsis induced indirect lung injury: immunomodulatory effects of Tregs and PD-1. J Leukoc Biol 96 (2014), 809–820.
19. 19 Tumeh, P., Harview, C., Yearley, J., Shintaku, I., Taylor, E., Robert, L., et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 515 (2014), 568–571.
20. 20 Guleria, I., Khosroshahi, A., Ansari, M., Habicht, A., Azuma, M., Yagita, H., et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 202 (2005), 231–237.
21. 21 Habicht, A., Dada, S., Jurewicz, M., Fife, B., Yagita, H., Azuma, M., et al. A link between PDL1 and T regulatory cells in fetomaternal tolerance. J Immunol 179 (2007), 5211–5219.
22. 22 Roger, T., Schneider, A., Weier, M., Sweep, F., Le Roy, D., Bernhagen, J., et al. High expression levels of macrophage migration inhibitory factor sustain the innate immune responses of neonates. Proc Natl Acad Sci U S A 113 (2016), E997–E1005.
23. 23 Belderbos, M., Levy, O., Meyaard, L., Bont, L., Plasma-mediated immune suppression: a neonatal perspective. Pediatr Allergy Immunol 24 (2013), 102–113.
24. 24 Chiesa, C., Pacifico, L., Natale, F., Hofer, N., Osborn, J., Resch, B., Fetal and early neonatal interleukin-6 response. Cytokine 76 (2015), 1–12.
25. 25 Lusyati, S., Hulzebos, C., Zandvoort, J., Sauer, P., Levles of 25 cytokines in the first seven days of life in newborn infants. BMC Res Notes, 6, 2013, 547.
26. 26 Tarrio, M., Grabie, N., Bu, D., Sharpe, A., Lichtman, A., PD-1 protects against inflammation and myocyte damage in T cell mediated myocarditis. J Immunol 188 (2012), 4876–4884.
27. 27 Basha, S., Surendran, N., Pichichero, M., Immune responses in neonates. Expert Rev Clin Immunol 10 (2014), 1171–1184.
28. 28 Freeman, G., Long, A., Iwai, Y., Bourque, K., Chernova, T., Nishimura, H., et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 192 (2000), 1027–1034.
29. 29 Chang, W., Kim, J., Kim, Y., Kim, Y., Lee, J., Azuma, M., et al. Cutting edge: programmed death-1/programmed death ligand-1 interaction regulates the induction and maintenance of invariant NKT cell anergy. J Immunol 181 (2008), 6707–6710.
30. 30 Licata, L., Nguyen, C., Burga, R., Falanga, V., Espat, N., Ayala, A., et al. Biliary obstruction results in PD1 dependent liver T-cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 94 (2013), 813–823.
31. 31 Okazaki, T., Honjo, T., PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19 (2007), 813–824.
32. 32 Tian, C., Kron, G., Dischert, K., Higginbotham, J., Crowe, J., Low expression of the interleukin (IL)-4 receptor alpha chain and reduced signaling via the IL-4 receptor complex in human neonatal B cells. Immunology 119 (2006), 54–62.
33. 33 Miscia, S., Di Baldassarre, A., Sabatino, G., Bonvini, E., Rana, R., Vitale, M., et al. Inefficient phospholipase C activation and reduced Lck expression characterize the signaling defect of umbilical cord T-lymphocytes. J Immunol 163 (1999), 2416–2424.